Several companies are moving forward with their initial public offerings (IPOs), adjusting their pricing and share offerings. Protein-shake maker Applied Nutrition is likely to price its IPO in London toward the bottom of its marketed price range. Chinese kitchen equipment maker Li Bang ($LBGJ) has priced its downsized US IPO at $4, below the initial range. Consumer products firm Synergy CHC ($SNYR) has priced its Nasdaq uplisting at $9, the low end of the range. High Roller is plotting a NYSE IPO at $8 per share. Septerna Inc ($SEPN), backed by Goldman Sachs, has upsized its IPO to 15.27 million shares from 10.937 million shares, with a new price range of $18-$18, aiming for a valuation of $743.1 million and seeking to raise $275 million, indicating strong investor interest in the biotech sector.